BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11256656)

  • 1. Topiramate as add-on treatment for patients with bipolar mania.
    Chengappa KN; Rathore D; Levine J; Atzert R; Solai L; Parepally H; Levin H; Moffa N; Delaney J; Brar JS
    Bipolar Disord; 1999 Sep; 1(1):42-53. PubMed ID: 11256656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
    Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
    CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive topiramate in bipolar II disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Torrent C; Benabarre A; Colom F; Martínez-Arán A; Reinares M; Comes M; Corbella B
    World J Biol Psychiatry; 2003 Oct; 4(4):172-6. PubMed ID: 14608588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
    Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS
    J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant properties of anticonvulsant drugs for bipolar disorder.
    Ernst CL; Goldberg JF
    J Clin Psychopharmacol; 2003 Apr; 23(2):182-92. PubMed ID: 12640220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of topiramate in treatment-resistant bipolar spectrum disorders.
    Vieta E; Torrent C; Garcia-Ribas G; Gilabert A; Garcia-Parés G; Rodriguez A; Cadevall J; García-Castrillón J; Lusilla P; Arrufat F
    J Clin Psychopharmacol; 2002 Aug; 22(4):431-5. PubMed ID: 12172346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.
    Macdonald KJ; Young LT
    CNS Drugs; 2002; 16(8):549-62. PubMed ID: 12096935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.
    Perugi G; Toni C; Ruffolo G; Sartini S; Simonini E; Akiskal H
    Pharmacopsychiatry; 1999 Jul; 32(4):136-41. PubMed ID: 10505483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
    Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J
    J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin in the acute treatment of refractory bipolar disorder.
    Altshuler LL; Keck PE; McElroy SL; Suppes T; Brown ES; Denicoff K; Frye M; Gitlin M; Hwang S; Goodman R; Leverich G; Nolen W; Kupka R; Post R
    Bipolar Disord; 1999 Sep; 1(1):61-5. PubMed ID: 11256659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
    Pande AC; Crockatt JG; Janney CA; Werth JL; Tsaroucha G
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar disorders and the effectiveness of novel anticonvulsants.
    Calabrese JR; Shelton MD; Rapport DJ; Kimmel SE
    J Clin Psychiatry; 2002; 63 Suppl 3():5-9. PubMed ID: 11908919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.
    McIntyre RS; Mancini DA; McCann S; Srinivasan J; Sagman D; Kennedy SH
    Bipolar Disord; 2002 Jun; 4(3):207-13. PubMed ID: 12180276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel treatments for bipolar disorder.
    Bowden CL
    Expert Opin Investig Drugs; 2001 Apr; 10(4):661-71. PubMed ID: 11281816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR;
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.
    Cabras PL; Hardoy MJ; Hardoy MC; Carta MG
    J Clin Psychiatry; 1999 Apr; 60(4):245-8. PubMed ID: 10221286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder.
    De León OA
    Harv Rev Psychiatry; 2001; 9(5):209-22. PubMed ID: 11553525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.